Proteome Sciences plc (PMSNF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.44 Million USD | -334.71% |
| 2022 | 1.32 Million USD | 1261.36% |
| 2021 | 97.32 Thousand USD | -75.86% |
| 2020 | 403.25 Thousand USD | 170.64% |
| 2019 | 149 Thousand USD | 108.91% |
| 2018 | -1.67 Million GBP | 50.49% |
| 2017 | -3.37 Million GBP | -19.9% |
| 2016 | -2.81 Million GBP | 29.67% |
| 2015 | -4 Million GBP | -12.34% |
| 2014 | -3.56 Million GBP | -13.24% |
| 2013 | -3.14 Million GBP | 25.96% |
| 2012 | -4.25 Million GBP | -7.49% |
| 2011 | -3.95 Million GBP | -186.73% |
| 2010 | 4.56 Million GBP | 213.79% |
| 2009 | -4.01 Million GBP | 13.28% |
| 2008 | -4.62 Million GBP | 11.96% |
| 2007 | -5.25 Million GBP | 6.85% |
| 2006 | -5.63 Million GBP | 18.25% |
| 2005 | -6.89 Million GBP | -32.66% |
| 2004 | -5.19 Million GBP | 23.33% |
| 2003 | -6.78 Million GBP | -64.99% |
| 2002 | -4.11 Million GBP | -107.89% |
| 2001 | -1.97 Million GBP | -40.71% |
| 2000 | -1.4 Million GBP | -14.23% |
| 1999 | -1.23 Million GBP | 33.55% |
| 1998 | -1.85 Million GBP | -23.65% |
| 1997 | -1.49 Million GBP | 5.91% |
| 1996 | -1.59 Million GBP | 0.0% |
| 1994 | -20 Thousand GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.79 Million USD | 0.0% |
| 2023 Q2 | -733.65 Thousand USD | 0.0% |
| 2023 FY | -3.1 Million USD | -334.71% |
| 2023 Q4 | -2.37 Million USD | 0.0% |
| 2022 FY | 1.32 Million USD | 1261.36% |
| 2022 Q2 | 76.67 Thousand USD | 0.0% |
| 2022 Q4 | 1.52 Million USD | 0.0% |
| 2021 FY | 97.32 Thousand USD | -75.86% |
| 2021 Q2 | -587.11 Thousand USD | 0.0% |
| 2021 Q4 | 671.84 Thousand USD | 0.0% |
| 2020 Q4 | 1.1 Million USD | 0.0% |
| 2020 FY | 403.25 Thousand USD | 170.64% |
| 2020 Q2 | -635.09 Thousand USD | 0.0% |
| 2019 Q4 | 761.73 Thousand USD | 0.0% |
| 2019 FY | 149 Thousand USD | 108.91% |
| 2019 Q2 | -542.17 Thousand USD | 0.0% |
| 2018 FY | -1.67 Million GBP | 50.49% |
| 2017 FY | -3.37 Million GBP | -19.9% |
| 2016 FY | -2.81 Million GBP | 29.67% |
| 2015 FY | -4 Million GBP | -12.34% |
| 2014 FY | -3.56 Million GBP | -13.24% |
| 2013 FY | -3.14 Million GBP | 25.96% |
| 2012 FY | -4.25 Million GBP | -7.49% |
| 2011 FY | -3.95 Million GBP | -186.73% |
| 2010 FY | 4.56 Million GBP | 213.79% |
| 2009 FY | -4.01 Million GBP | 13.28% |
| 2008 FY | -4.62 Million GBP | 11.96% |
| 2007 FY | -5.25 Million GBP | 6.85% |
| 2006 FY | -5.63 Million GBP | 18.25% |
| 2005 FY | -6.89 Million GBP | -32.66% |
| 2004 FY | -5.19 Million GBP | 23.33% |
| 2003 FY | -6.78 Million GBP | -64.99% |
| 2002 FY | -4.11 Million GBP | -107.89% |
| 2001 FY | -1.97 Million GBP | -40.71% |
| 2000 FY | -1.4 Million GBP | -14.23% |
| 1999 FY | -1.23 Million GBP | 33.55% |
| 1998 FY | -1.85 Million GBP | -23.65% |
| 1997 FY | -1.49 Million GBP | 5.91% |
| 1996 FY | -1.59 Million GBP | 0.0% |
| 1994 FY | -20 Thousand GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -73.262% |
| Arrayit Corporation | -3.31 Million USD | 26.318% |
| Atlantic International Corp. | -5.62 Million USD | 56.589% |
| Biocept, Inc. | -32.08 Million USD | 92.386% |
| Bioqual, Inc. | 483.48 Thousand USD | 605.294% |
| CardioGenics Holdings Inc | -1.91 Million USD | -27.484% |
| DermTech, Inc. | -100.88 Million USD | 97.579% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.121% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 88.687% |
| iMD Companies, Inc. | -200.63 Thousand USD | -1117.628% |
| IDenta Corp. | 14.64 Thousand USD | 16782.6% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 404.613% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 6414.456% |
| InVitro International | 1553.00 USD | 157408.435% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 71.567% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -4103.951% |
| Medical Imaging Corp. | -3.02 Million USD | 19.187% |
| NovelStem International Corp. | -4.18 Million USD | 41.657% |
| Optigenex Inc. | -2.89 Million USD | 15.694% |
| PharmChem, Inc. | 845.1 Thousand USD | 389.078% |
| Response Genetics, Inc | -20.18 Million USD | 87.896% |
| Rennova Health, Inc. | -3.29 Million USD | 25.814% |
| RushNet, Inc. | -607.02 Thousand USD | -302.453% |
| ScreenPro Security Inc. | -2.24 Million USD | -8.637% |
| Stella Diagnostics Inc. | -5.7 Million USD | 57.196% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 78.599% |
| Todos Medical Ltd. | -24.99 Million USD | 90.226% |